Your browser doesn't support javascript.
loading
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial.
Madan, Anuradha; Collins, Harry; Sheldon, Eric; Frenette, Louise; Chu, Laurence; Friel, Damien; Drame, Mamadou; Vaughn, David W; Innis, Bruce L; Schuind, Anne.
  • Madan A; GSK, 1250 South Collegeville Road, Collegeville, PA 19426, USA. Electronic address: Anu.2.Madan@gsk.com.
  • Collins H; Anderson & Collins, Clinical Research Inc., Edison, NJ 08817, USA.
  • Sheldon E; Miami Research Associates, 6141 Sunset Drive Suite 501, Miami, FL 33143, USA.
  • Frenette L; QT Research, 2185 King Ouest, Suite 101, Sherbrooke JIJ 2G2, Canada.
  • Chu L; Benchmark Research, 3100 Red River St, Ste 1, Austin, TX 78705, USA.
  • Friel D; GSK Vaccines, 20 Avenue Fleming, 1300 Wavre, Belgium.
  • Drame M; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.
  • Vaughn DW; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.
  • Innis BL; GSK, 2301 Renaissance Blvd, King of Prussia, PA 19406-2772, USA.
  • Schuind A; GSK, 14200 Shady Grove Road, Rockville, MD 20850, USA.
Vaccine ; 35(35 Pt B): 4621-4628, 2017 08 16.
Article en En | MEDLINE | ID: mdl-28720281

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Escualeno / Vacunas contra la Influenza / Adyuvantes Inmunológicos / Alfa-Tocoferol / Subtipo H9N2 del Virus de la Influenza A / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Escualeno / Vacunas contra la Influenza / Adyuvantes Inmunológicos / Alfa-Tocoferol / Subtipo H9N2 del Virus de la Influenza A / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article